Roffman Miller Associates Inc. PA Reduces Stock Holdings in Danaher Co. (NYSE:DHR)

Roffman Miller Associates Inc. PA lowered its position in Danaher Co. (NYSE:DHR) by 2.4% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 40,765 shares of the conglomerate’s stock after selling 1,023 shares during the quarter. Roffman Miller Associates Inc. PA’s holdings in Danaher were worth $9,358,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently modified their holdings of DHR. South Dakota Investment Council boosted its stake in Danaher by 5.8% during the fourth quarter. South Dakota Investment Council now owns 12,682 shares of the conglomerate’s stock worth $2,911,000 after buying an additional 700 shares during the period. World Equity Group Inc. boosted its stake in Danaher by 6.0% during the fourth quarter. World Equity Group Inc. now owns 2,726 shares of the conglomerate’s stock worth $626,000 after buying an additional 154 shares during the period. Delta Financial Group Inc. purchased a new position in Danaher during the fourth quarter worth about $1,061,000. Cabot Wealth Management Inc. boosted its stake in Danaher by 53.5% during the fourth quarter. Cabot Wealth Management Inc. now owns 41,595 shares of the conglomerate’s stock worth $9,548,000 after buying an additional 14,491 shares during the period. Finally, MONECO Advisors LLC boosted its stake in Danaher by 13.5% during the fourth quarter. MONECO Advisors LLC now owns 1,502 shares of the conglomerate’s stock worth $345,000 after buying an additional 179 shares during the period. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Insider Buying and Selling

In related news, SVP Brian W. Ellis sold 5,700 shares of Danaher stock in a transaction dated Thursday, January 30th. The stock was sold at an average price of $224.13, for a total value of $1,277,541.00. Following the transaction, the senior vice president now owns 20,230 shares of the company’s stock, valued at approximately $4,534,149.90. This trade represents a 21.98 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 11.10% of the stock is owned by corporate insiders.

Wall Street Analysts Forecast Growth

Several research analysts have recently commented on DHR shares. JPMorgan Chase & Co. lowered their price objective on shares of Danaher from $310.00 to $300.00 and set an “overweight” rating for the company in a research note on Tuesday, January 28th. Scotiabank started coverage on shares of Danaher in a research note on Monday, December 23rd. They issued a “sector perform” rating and a $265.00 price objective for the company. Guggenheim started coverage on shares of Danaher in a research note on Thursday, December 19th. They issued a “buy” rating and a $275.00 price objective for the company. Wells Fargo & Company lowered their price objective on shares of Danaher from $280.00 to $240.00 and set an “equal weight” rating for the company in a research note on Thursday, January 30th. Finally, StockNews.com lowered shares of Danaher from a “buy” rating to a “hold” rating in a research note on Saturday, December 14th. Seven equities research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the stock. Based on data from MarketBeat, Danaher presently has an average rating of “Moderate Buy” and an average price target of $278.00.

Danaher Stock Up 0.9 %

DHR stock opened at $209.86 on Monday. The firm has a 50 day simple moving average of $226.71 and a 200-day simple moving average of $246.84. Danaher Co. has a twelve month low of $196.80 and a twelve month high of $281.70. The company has a market capitalization of $151.58 billion, a P/E ratio of 39.75, a PEG ratio of 2.66 and a beta of 0.83. The company has a current ratio of 1.40, a quick ratio of 1.05 and a debt-to-equity ratio of 0.31.

Danaher (NYSE:DHR) last posted its earnings results on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $2.14. Danaher had a return on equity of 10.82% and a net margin of 16.33%. During the same period in the previous year, the business earned $2.09 EPS. On average, equities research analysts predict that Danaher Co. will post 7.63 earnings per share for the current fiscal year.

Danaher Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, April 25th. Investors of record on Friday, March 28th will be issued a dividend of $0.32 per share. This is a positive change from Danaher’s previous quarterly dividend of $0.27. This represents a $1.28 dividend on an annualized basis and a yield of 0.61%. Danaher’s payout ratio is presently 20.45%.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.